{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:43:58Z","timestamp":1759970638267,"version":"build-2065373602"},"reference-count":43,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Gorham-Stout syndrome (GSD), also known as disappearing bone disease, is an extremely rare bone disorder, characterized by a huge bone loss, which is followed by a lack of new matrix deposition and an excessive proliferation of both blood vessels and lymphatics. Unfortunately, the biological causes of GSD are still unknown. Recent studies that have tried to understand the etiopathogenesis of GSD have been principally focused on the vascular and osteoclastogenic aspects, not considering the possibility of a lack of osteoblast function. Nowadays, a diagnosis is still difficult, and is often made by exclusion of the presence of other pathologies, as well as on radiological evidence, and finally confirmed by histological examination. Treatment also remains a critical issue for clinicians today, who mostly try to control the progression of the disease. Over the last two decades, clear evidence has emerged that the endocannabinoid system plays an important role in bone metabolism, leading scientists to hypothesize that it could be involved in physiological and pathological bone processes. In this work, we analyzed the presence of the ES in a primary cell line of human mesenchymal stem cells derived from a GSD patient for the first time, to understand if and how this complex network may play a role in the pathogenesis of the syndrome. Our preliminary results demonstrated that the ES is also present in the pathological tissue. Moreover, the qRT-PCR analysis showed an altered expression of the different ES components (i.e., CNR1, CNR2, TRPV1, and GPR55). We observed an upregulation of CNR1 and TRPV1 expression, while the opposite trend was noticed for CNR2 and GPR55 expression. Thus, these results could lead us to speculate that possible deregulation of the ES may play an important role in the lack of bone regeneration in GSD patients. However, further studies will be necessary to confirm the role of the ES in the progression of GSD and understand whether the natural components of Cannabis Sativa could play a therapeutic role in the treatment of the disease.<\/jats:p>","DOI":"10.3390\/ijms26031143","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T08:57:48Z","timestamp":1738054668000},"page":"1143","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Presence of the Endocannabinoid System in an In Vitro Model of Gorham-Stout Disease and Its Possible Role in the Pathogenesis"],"prefix":"10.3390","volume":"26","author":[{"given":"Cinzia","family":"Aurilia","sequence":"first","affiliation":[{"name":"Department of Experimental and Clinical Biomedical Sciences, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8376-7404","authenticated-orcid":false,"given":"Gaia","family":"Palmini","sequence":"additional","affiliation":[{"name":"Fondazione Italiana Ricerca sulle Malattie dell\u2019Osso (FIRMO Onlus), 50141 Florence, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Donati","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Biomedical Sciences, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Falsetti","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Biomedical Sciences, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianna","family":"Galli","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Biomedical Sciences, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Margheriti","sequence":"additional","affiliation":[{"name":"Stabilimento Chimico Farmaceutico Militare (SCFM)\u2014Agenzia Industrie Difesa (AID), 50141 Florence, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7461-330X","authenticated-orcid":false,"given":"Teresa","family":"Iantomasi","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Biomedical Sciences, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arcangelo","family":"Moro","sequence":"additional","affiliation":[{"name":"Stabilimento Chimico Farmaceutico Militare (SCFM)\u2014Agenzia Industrie Difesa (AID), 50141 Florence, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8741-0592","authenticated-orcid":false,"given":"Maria Luisa","family":"Brandi","sequence":"additional","affiliation":[{"name":"Fondazione Italiana Ricerca sulle Malattie dell\u2019Osso (FIRMO Onlus), 50141 Florence, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.57582\/IJBF.230302.065","article-title":"Gorham-Stout Disease","volume":"3","author":"Aurilia","year":"2023","journal-title":"Int. J. Bone Fragility"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"694","DOI":"10.5312\/wjo.v5.i5.694","article-title":"Vanishing Bone Disease (Gorham-Stout Syndrome): A Review of a Rare Entity","volume":"5","author":"Nikolaou","year":"2014","journal-title":"World J. Orthop."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3121\/cmr.3.2.65","article-title":"Gorham\u2019s Disease or Massive Osteolysis","volume":"3","author":"Patel","year":"2005","journal-title":"Clin. Med. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1530\/EOR-21-0083","article-title":"Current Concepts from Diagnosis to Management in Gorham-Stout Disease: A Systematic Narrative Review of about 350 Cases","volume":"7","author":"Angelini","year":"2022","journal-title":"EFORT Open Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.2214\/ajr.135.5.1084","article-title":"Massive Osteolysis in an Infant","volume":"135","author":"Abrahams","year":"1980","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/00004728-199411000-00027","article-title":"CT and MRI of Massive Osteolysis of Gorham","volume":"18","author":"Assoun","year":"1994","journal-title":"J. Comput. Assist. Tomogr."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00003072-198702000-00022","article-title":"Comparative Imaging. Massive Osteolysis (Gorham\u2019s Syndrome, Disappearing Bone Disease)","volume":"12","author":"Marymont","year":"1987","journal-title":"Clin. Nucl. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/BF02012145","article-title":"Gorham\u2019s Disease Involving the Thoracic Skeleton. Plain Films and CT in Two Cases","volume":"23","author":"Mitchell","year":"1993","journal-title":"Pediatr. Radiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s002560050306","article-title":"Gorham\u2019s Disease of the Radius: Radiographic, Scintigraphic, and MRI Findings with Pathologic Correlation","volume":"26","author":"Spieth","year":"1997","journal-title":"Skeletal Radiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.2106\/00004623-196951080-00017","article-title":"Sequential Roentgenographic Changes Occurring in Massive Osteolysis","volume":"51","author":"Torg","year":"1969","journal-title":"J. Bone Joint Surg. Am."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0030-4220(83)90185-8","article-title":"Perspectives on Massive Osteolysis. Report of a Case and Review of the Literature","volume":"55","author":"Heffez","year":"1983","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Lowe, H., Toyang, N., Steele, B., Bryant, J., and Ngwa, W. (2021). The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22179472"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Saponaro, F., Ferrisi, R., Gado, F., Polini, B., Saba, A., Manera, C., and Chiellini, G. (2021). The Role of Cannabinoids in Bone Metabolism: A New Perspective for Bone Disorders. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222212374"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"84","DOI":"10.57582\/IJBF.220203.084","article-title":"Cannabinoids: New Friends in Bone Fracture and in Joint Disease Prevention?","volume":"2","author":"Palmini","year":"2022","journal-title":"Int. J. Bone Fragility"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1073\/pnas.0504187103","article-title":"Peripheral Cannabinoid Receptor, CB2, Regulates Bone Mass","volume":"103","author":"Ofek","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/cpt.119","article-title":"Cannabinoids: Friend or Foe?","volume":"97","author":"Tyndale","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/03602532.2019.1574303","article-title":"Cannabinoids and Bone Regeneration","volume":"51","author":"Apostu","year":"2019","journal-title":"Drug Metab. Rev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cmet.2009.07.006","article-title":"Cannabinoid Receptor Type 1 Protects against Age-Related Osteoporosis by Regulating Osteoblast and Adipocyte Differentiation in Marrow Stromal Cells","volume":"10","author":"Idris","year":"2009","journal-title":"Cell Metab."},{"key":"ref_19","first-page":"504","article-title":"Activation of Cannabinoid Receptor CB2 Regulates Osteogenic and Osteoclastogenic Gene Expression in Human Periodontal Ligament Cells","volume":"45","author":"Qian","year":"2010","journal-title":"J. Periodontal Res."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Mechoulam, R. (2005). Cannabinoids as Therapeutics, Birkh\u00e4user.","DOI":"10.1007\/3-7643-7358-X"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1515\/jbcpp-2015-0073","article-title":"The Skeletal Endocannabinoid System: Clinical and Experimental Insights","volume":"27","author":"Raphael","year":"2016","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Rossi, F., Tortora, C., Punzo, F., Bellini, G., Argenziano, M., Di Paola, A., Torella, M., and Perrotta, S. (2019). The Endocannabinoid\/Endovanilloid System in Bone: From Osteoporosis to Osteosarcoma. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20081919"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2106\/00004623-195537050-00008","article-title":"Massive Osteolysis (Acute Spontaneous Absorption of Bone, Phantom Bone, Disappearing Bone); Its Relation to Hemangiomatosis","volume":"37-A","author":"Gorham","year":"1955","journal-title":"J. Bone Joint Surg. Am."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2106\/00004623-197759010-00009","article-title":"Disappearing Bone Disease. A Clinical and Histological Study","volume":"59","author":"Heyden","year":"1977","journal-title":"J. Bone Joint Surg. Am."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1124\/mol.106.026435","article-title":"Involvement of Neuronal Cannabinoid Receptor CB1 in Regulation of Bone Mass and Bone Remodeling","volume":"70","author":"Tam","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00223-010-9378-8","article-title":"Cannabinoids and Bone: Friend or Foe?","volume":"87","author":"Idris","year":"2010","journal-title":"Calcif. Tissue Int."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"796715","DOI":"10.1155\/2013\/796715","article-title":"The Cannabinoid Receptor Type 1 Is Essential for Mesenchymal Stem Cell Survival and Differentiation: Implications for Bone Health","volume":"2013","author":"Gowran","year":"2013","journal-title":"Stem Cells Int."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/sj.bjp.0707593","article-title":"Cannabinoid Receptors and the Regulation of Bone Mass","volume":"153","author":"Bab","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.plipres.2013.05.004","article-title":"Cannabinoid Receptor Signaling in Progenitor\/Stem Cell Proliferation and Differentiation","volume":"52","author":"Bari","year":"2013","journal-title":"Prog. Lipid Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1210\/en.2010-0881","article-title":"\u03922-Adrenergic Receptor Signaling in Osteoblasts Contributes to the Catabolic Effect of Glucocorticoids on Bone","volume":"152","author":"Ma","year":"2011","journal-title":"Endocrinology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2174\/157015910792246173","article-title":"Cannabinoid Receptors as Target for Treatment of Osteoporosis: A Tale of Two Therapies","volume":"8","author":"Idris","year":"2010","journal-title":"Curr. Neuropharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1210\/en.2010-0930","article-title":"The Type 2 Cannabinoid Receptor Regulates Bone Mass and Ovariectomy-Induced Bone Loss by Affecting Osteoblast Differentiation and Bone Formation","volume":"152","author":"Sophocleous","year":"2011","journal-title":"Endocrinology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/j.bone.2010.10.124","article-title":"Peripheral Cannabinoid Type 2 Receptor Regulates Osteoclast Formation, MDA-MB-231 Breast Cancer Cell Migration and Bone Marrow\/Tumour Cell Interaction via PI3 Kinase\/AKT and P38 Pathways","volume":"48","author":"Sophocleous","year":"2011","journal-title":"Bone"},{"key":"ref_34","unstructured":"(2025, January 15). Handbook of Cannabis and Related Pathologies: Biology, Pharmacology, Diagnosis, and Treatment. Available online: https:\/\/www.researchgate.net\/publication\/317198774_Handbook_of_Cannabis_and_Related_Pathologies_Biology_Pharmacology_Diagnosis_and_Treatment."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12964-020-0512-6","article-title":"Activation of Cannabinoid Receptor Type 2-Induced Osteogenic Differentiation Involves Autophagy Induction and P62-Mediated Nrf2 Deactivation","volume":"18","author":"Xu","year":"2020","journal-title":"Cell Commun. Signal. CCS"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1093\/hmg\/ddi370","article-title":"Cannabinoid Receptor Type 2 Gene Is Associated with Human Osteoporosis","volume":"14","author":"Karsak","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.phrs.2015.06.010","article-title":"CB(2) and TRPV(1) Receptors Oppositely Modulate in Vitro Human Osteoblast Activity","volume":"99","author":"Rossi","year":"2015","journal-title":"Pharmacol. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.bone.2008.10.056","article-title":"The Endovanilloid\/Endocannabinoid System in Human Osteoclasts: Possible Involvement in Bone Formation and Resorption","volume":"44","author":"Rossi","year":"2009","journal-title":"Bone"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"16511","DOI":"10.1073\/pnas.0902743106","article-title":"The Putative Cannabinoid Receptor GPR55 Affects Osteoclast Function in Vitro and Bone Mass in Vivo","volume":"106","author":"Whyte","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.bcp.2013.11.016","article-title":"Increase of Mesenchymal Stem Cell Migration by Cannabidiol via Activation of P42\/44 MAPK","volume":"87","author":"Schmuhl","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Xin, Y., Tang, A., Pan, S., and Zhang, J. (2021). Components of the Endocannabinoid System and Effects of Cannabinoids Against Bone Diseases: A Mini-Review. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.793750"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Almogi-Hazan, O., and Or, R. (2020). Cannabis, the Endocannabinoid System and Immunity\u2014the Journey from the Bedside to the Bench and Back. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21124448"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Braile, M., Marcella, S., Marone, G., Galdiero, M.R., Varricchi, G., and Loffredo, S. (2021). The Interplay between the Immune and the Endocannabinoid Systems in Cancer. Cells, 10.","DOI":"10.3390\/cells10061282"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/3\/1143\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:37:50Z","timestamp":1759919870000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/3\/1143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,28]]},"references-count":43,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["ijms26031143"],"URL":"https:\/\/doi.org\/10.3390\/ijms26031143","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2025,1,28]]}}}